OMNIACTIVE SPONSORS HAPPI WEBINAR FEATURING COSMETIC EXPERT DISCUSSING LATEST LUTEMAX 2020 SKIN HEALTH STUDY

OMNIACTIVE SPONSORS HAPPI WEBINAR FEATURING COSMETIC EXPERT DISCUSSING LATEST LUTEMAX 2020 SKIN HEALTH STUDY

OmniActive is sponsoring the Happi webinar “Game Changing Clinical Research on Skin Health” on Thursday, September 15th at 2 p.m. EST. Dr. Alain Khaiat Ph.D., a leading, globally-renowned cosmetics expert will be guest speaking sharing the latest science, trends and opportunities driving the booming skin health and beauty markets. OmniActive invites industry members to join the webinar to learn more about the surprising benefits of oral supplementation of Lutemax 2020 enhanced lutein and zeaxanthin isomers to help promote healthy skin over a lifetime at https://event.webcasts.com/viewer/event.jsp?ei=1115077.

As Boomer and even Millennials take a more proactive and therapeutic approach to improved skin health, an increasing interest by manufacturers reflects this healthy aging trend. It is estimated currently there are 800 million 60+ women in the U.S. and by 2050 that number is estimated to reach 2 billion. With the growing demand for clinically-proven, safe ingredients in the skin health category, OmniActive conducted a 12-week double-blind placebo controlled study where researchers supplemented healthy individuals with mild to moderate dry skin using Lutemax 2020 lutein with enhanced zeaxanthin isomers. Lutemax 2020 supplementation resulted in a rare combination of outcomes for more beautiful, healthy skin; benefits included even-toned, clear skin, skin lightening and brightening as well as protecting the skin against the damaging rays of the sun.

"The latest science supports Lutemax 2020’s role in various, rapidly growing categories including skin health and beauty from within,” said Lynda Doyle, Sr. VP of OmniActive Health Technologies. “In support of OmniActive Health Technologies’ robust clinical program for Lutemax 2020, this webinar was developed to give industry members unique insight into the burgeoning research on skin health and macular carotenoids.”

OmniActive will also be exhibiting at Happi’s 2016 Anti-Aging Conference & Tabletop Exhibition, which will be held Sept. 20 & 21 at the Hyatt Regency, New Brunswick, NJ. OmniActive's tabletop number is 10 for the one-day exhibition on September 20.

About Alain Khaiat, Ph.D. 

Dr. Khaiat was awarded the first in-cosmetics Lifetime Achievement Award in Paris in April 2010, and has more than 35 years of experience in the cosmetic industry having served as a V.P. R&D and QA with industry leaders such as Johnson & Johnson, Yves Rocher and Revlon as well as created SEERS Consulting in 2006. Dr. Khaiat is President of the CTFA of Singapore, V.P. Technical and Scientific Body, member of the International Dialogue for the Evaluation of Allergens (IDEA) Supervisory Group, a joint project between IFRA and the EU commission and the Chairman of the ISO TC 217 (cosmetics). 

About Happi 

HAPPI is the leading media outlet in the global personal care and household product market. Celebrating 50 years of global coverage in 2013, Happi provides in-depth analysis of this $530 billion market for their 16,500 subscribers around the world. In recent years, Happi added features on a variety of subjects, expanded coverage in fast-growing markets in Asia and Latin America, and even added new events such as Anti-Aging Conference & Tabletop Exhibition.

About OmniActive Health Technologies

OmniActive Health Technologies (www.omniactives.com) offers a range of quality ingredients, that are innovative and scientifically validated to address complex challenges for customers in the dietary supplement, food and beverage space using technology-driven, sustainable solutions with application support within a global regulatory framework. OmniActive’s core products include carotenoids, plant extracts and specialty functional ingredients. The company develops IP-protected, science-backed branded ingredients from natural sources using cutting edge technologies. OmniActive leverages international R&D strengths to deploy an array of state of the art manufacturing technologies in extraction, purification, isolation and delivery of nutritional actives. Clinical research–geared towards demonstrating efficacy and claim substantiation–is the cornerstone of OmniActive’s R&D activities. The company’s centers of excellence are located in North America and India, whereas its cGMP and HACCP system-compliant manufacturing operations are located at multiple FDA inspected sites in India. Whether looking for a new ingredient to add to a finished product, or technology to enhance an existing ingredient, OmniActive delivers unmatched innovation.

go back to PRESS RELEASES